World Bank Data Suggests Automation Could Threaten 69 of Jobs in India Micron Technology Surges Idaho Chip Makers Market Cap Doubles to 1 Trillion in 48 Days EEOC Faces Potential Shutdown of Longstanding Pay Data Collection Program Used to Combat Workplace Discrimination JK Tyre Charts Rs 4900 Crore Capex to Expand Capacity by 24 Through FY30 London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance Jim Cramer Advises Holding Astera Labs I Say You Hold On DaVita Inc DVA Q1 2026 Earnings Strong EPS Beat Highlights Operational Discipline Diversified Energy Company DEC Q2 2024 Earnings Strong EPS Beat Bolsters Operational Performance Narrative Rockwell Medical Q1 2026 Earnings Wider Loss Stock Declines as Revenue Details Linger Hour Loop Inc HOUR Q4 2024 Earnings Narrowing Loss Amid Quiet Quarter OVLY Q3 2023 Earnings EPS of 089 Reported Amidst Flat Market Reaction CON Q1 2026 Earnings EPS Surpasses Estimates by 17 Swvl Holdings SWVL Experiences Sharp Decline Testing Critical Support Levels Rollins ROL Edges Lower as Consolidation Persists Near 50 Eureka Acquisition Corp EURK Trading in a Tight Range Near 115 Support and Resistance Levels in Focus Hyperfine Inc HYPR Slides 271 as Stock Tests Critical Support Levels BCB Bancorp Inc BCBP Gains Ground Rising Momentum Signals Potential Breakout A Family Dilemma Timing the CashOut of Inherited CDs During Hospice Care FIBK Q1 2026 Earnings Slight Earnings Miss Amidst Steady Operations IO Biotech Holds Steady at 005 Navigating Extremely Low Valuation Territory ROP Q1 2026 Earnings Earnings Beat Driven by Strong Execution in Software and Industrial Portfolios EDN Q4 2024 Earnings Massive EPS Surprise Masks Broader Concerns as Stock Declines VBNK Q1 2026 Earnings EPS Misses Estimates as Earnings Fall Short Nauticus Robotics Inc KITT Q3 2024 Earnings Deep EPS Miss Reflects PreRevenue Development Stage National Presto Industries Inc Q3 2023 Earnings Solid EPS Performance Drives Positive Stock Reaction Bragg Gaming Group BRAG Q1 2026 Earnings Narrowing Losses as EPS Surpasses Street Views Lyell Immunopharma Q1 2026 Earnings Narrower Loss Surprises Expectations Amid Clinical Progress